Skip to main content

Table 2 MSC immunophenotypic analysis of PL-MSCs versus FBS-MSCs

From: Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience

  CD90 CD105 CD73 HLA-DR CD45 CD14 CD19 CD34
FBS-MSCs 95.5 ± 1.6 96.8 ± 1.5 98.7 ± 1.1 2.9 ± 0.8 0.3 ± 0.1 1.3 ± 0.5 1.6 ± 0.5 0.6 ± 0.1
PL-MSCs 96.6 ± 0.6 93.2 ± 2.6 97.7 ± 1.5 1.5 ± 0.3 0.2 ± 0.1 1.2 ± 0.2 1.4 ± 0.1 0.5 ± 0.1
  1. Values expressed as mean percentage ± SD of positive cells for MSC antigen expression
  2. n = 12. Cells analyzed at the third passage for each experimental condition. No significant differences were observed (p > 0.05)
  3. FBS fetal bovine serum, MSC mesenchymal stromal/stem cell, PL platelet lysate